Literature DB >> 8541194

Stenting without thrombolysis for aortoiliac occlusive disease: experience in 14 high-risk patients.

J L Ballard1, F C Taylor, S R Sparks, J D Killeen.   

Abstract

Stenting without thrombolysis of 16 occluded iliac artery segments and one occluded infrarenal abdominal aorta was attempted in 14 patients. All patients were either considered to be prohibitive operative risks or had contraindications to thrombolytic therapy. Indications for limb reperfusion included rest pain, disabling claudication, or dry gangrene. Successful recanalization was achieved primarily in 13 patients with self-expandable Wallstents, balloon-expandable Palmaz stents, or a combination of the two stents. Follow-up was carried out in all patients in whom recanalization was successful. All stented patients showed symptomatic improvement, and the mean preprocedure ankle/brachial index, which was 0.31, improved to 0.78 after the procedure (p = 0). Complications included a vertebrobasilar stroke during the procedure in one patient, perforation during angioplasty of a stenotic but nonoccluded external iliac artery in one, and dissection of the distal external iliac artery in one. Distal embolization did not occur. Percutaneous recanalization of aortoiliac occlusions without initial thrombolysis is possible and has a high potential for technical success. Additional data and longer follow-up are still needed, but this procedure may provide a reasonable, less invasive option in some patients at high surgical risk or in patients who have contraindications to thrombolytic therapy.

Entities:  

Mesh:

Year:  1995        PMID: 8541194     DOI: 10.1007/BF02143859

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  1 in total

1.  Stenting for proximal para-anastomotic stenosis of an infrarenal aortic bypass graft.

Authors:  Venkatesh Ramaiah; Charles Thompson; Adrian Harvey; Julio A Rodriguez; Edward B Diethrich
Journal:  Tex Heart Inst J       Date:  2002
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.